These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28394433)

  • 1. Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High-Dose Methotrexate.
    Drost SA; Wentzell JR; Giguère P; McLurg DL; Sabloff M; Kanji S; Nguyen TT
    Pharmacotherapy; 2017 Jun; 37(6):684-691. PubMed ID: 28394433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization: A pediatric experience.
    Diachinsky M; Tran T; Jupp J; McKinnon K
    J Oncol Pharm Pract; 2021 Jan; 27(1):119-127. PubMed ID: 32316877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate.
    Kintzel PE; Campbell AD; Yost KJ; Brinker BT; Arradaza NV; Frobish D; Wehr AM; O'Rourke TJ
    J Oncol Pharm Pract; 2012 Jun; 18(2):239-44. PubMed ID: 22075004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the impact of adding acetazolamide to oral or intravenous sodium bicarbonate as compared with intravenous bicarbonate monotherapy as urinary alkalinization in adults receiving high-dose methotrexate.
    Clemmons AB; Chase A; Duong P; Waller JL; Saunders K; Bryan L
    Support Care Cancer; 2021 Mar; 29(3):1527-1534. PubMed ID: 32725375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study.
    Mikkelsen TS; Mamoudou AD; Tuckuviene R; Wehner PS; Schroeder H
    Pediatr Blood Cancer; 2014 Feb; 61(2):297-301. PubMed ID: 24039194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of methotrexate clearance with an enteral urine alkalinization protocol for patients receiving high-dose methotrexate.
    Kramer E; Filtz M; Pace M
    J Oncol Pharm Pract; 2021 Jan; 27(1):26-32. PubMed ID: 32164493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia.
    Svahn T; Mellgren K; Harila-Saari A; Åsberg A; Kanerva J; Jónsson Ó; Vaitkeviciene G; Stamm Mikkelssen T; Schmiegelow K; Heldrup J
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Methods of Urinary Alkalinization for High-dose Methotrexate Administration: Alternatives to Intravenous Sodium Bicarbonate During a Critical Drug Shortage.
    Visage R; Kaiser N; Williams M; Kim A
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):371-375. PubMed ID: 30475303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicity.
    Wiczer T; Dotson E; Tuten A; Phillips G; Maddocks K
    J Oncol Pharm Pract; 2016 Jun; 22(3):430-6. PubMed ID: 26152702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of urine pH and flow on renal clearance of methotrexate.
    Sand TE; Jacobsen S
    Eur J Clin Pharmacol; 1981; 19(6):453-6. PubMed ID: 7250179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of sodium acetate use for urine alkalinization in patients receiving high dose methotrexate.
    Perkey CL; Flynn LA; Lentz K; Butler S
    J Oncol Pharm Pract; 2023 Jan; 29(1):119-124. PubMed ID: 34931924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical analysis of relation between plasma methotrexate concentration and toxicity in high-dose methotrexate therapy of childhood nonHodgkin lymphoma.
    Tsurusawa M; Gosho M; Mori T; Mitsui T; Sunami S; Kobayashi R; Fukano R; Tanaka F; Fujita N; Inada H; Koh K; Takimoto T; Saito A; Fujimoto J; Nakazawa A; Horibe K;
    Pediatr Blood Cancer; 2015 Feb; 62(2):279-284. PubMed ID: 25359701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucarpidase for the treatment of life-threatening methotrexate overdose.
    Tuffaha HW; Al Omar S
    Drugs Today (Barc); 2012 Nov; 48(11):705-11. PubMed ID: 23170306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes is a risk factor for high-dose methotrexate-associated AKI in lymphoma patients.
    Wang Y; Wei L; Guan Y; Wang Q; Xie Q; Hao C
    Ren Fail; 2020 Nov; 42(1):1111-1117. PubMed ID: 33164656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early therapeutic drug monitoring of methotrexate and its association with acute kidney injury: A retrospective cohort study.
    Tentoni N; Hwang M; Villanueva G; Combs R; Lowe J; Ramsey LB; Taylor ZL; Carrillo TM; Aumente MD; López-Viñau López T; Rizzari C; Howard SC
    Cancer Med; 2024 Sep; 13(17):e70176. PubMed ID: 39254047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study.
    Gros L; Roldán A; Cabero-Martínez A; Domínguez-Pinilla N; de la Fuente A; González-Barca E; Tasso M; Torrent M; Gallardo E; Del Cerro I; Giró-Perafita A; Badia X
    J Oncol Pharm Pract; 2023 Jun; 29(4):794-801. PubMed ID: 35147457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Predictors of Delayed Clearance and the Effect of Increased Hydration Rate on Methotrexate Clearance.
    Chen AR; Wang YM; Lin M; Kuo DJ
    Cureus; 2020 Jun; 12(6):e8674. PubMed ID: 32699674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survey of Methotrexate Prescription and Blood Concentration in Patients Treated with High-Dose Methotrexate].
    Kobayashi S; Yasu T; Momo K; Ohno N
    Gan To Kagaku Ryoho; 2020 Jul; 47(7):1063-1067. PubMed ID: 32668853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
    Widemann BC; Hetherington ML; Murphy RF; Balis FM; Adamson PC
    Cancer; 1995 Aug; 76(3):521-6. PubMed ID: 8625136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single assessment of methotrexate levels at 42 hours permits safe administration and early discharge in children with lymphoblastic lymphoma and leukemia receiving high-dose methotrexate.
    Totadri S; Srinivasan HN; Joseph LL; Boddu D; Mathew LG; John R
    Pediatr Hematol Oncol; 2021 Aug; 38(5):434-443. PubMed ID: 33764242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.